Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Biovitrum describes 5-HT2C ligands for obesity and other disorders

July 9, 2002

Another launch for human choriogonadotropin alfa

July 8, 2002

BMS describes aP2 inhibitors for use in diabetes and related disorders

July 8, 2002

New glucose uptake activators described in Ishihara Sangyo patent

July 8, 2002

Decitabine elevates fetal hemoglobin in all sickle cell anemia patients

July 8, 2002

Novel PPARalpha agonists in Lilly pipeline

July 5, 2002

Schering AG acquires distribution rights for Testogel in Europe

July 5, 2002

Xenical improves weight loss and glycemic control in type 2 diabetes patients on metformin

July 5, 2002

Synthesis of sst2 agonists and their use in diabetes and other conditions

July 4, 2002

Taisho designs cyanopyrrolidine DPP-IV inhibitors

July 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...